| |
| |
|
| Insider
Information: |
Bradley Scott |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
18,764,302 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$7,251,242 |
|
|
| Total
Shares |
18,764,302 |
|
|
| Total
Value |
$7,251,242 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bioenvision Inc |
BIVN |
10% Owner |
|
0 |
2007-08-17 |
6,663,083 |
Premium* |
|
|
XTL Biopharmaceuticals Ltd |
XTLBY |
10% Owner |
|
0 |
2008-06-10 |
3,072,560 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
10% Owner |
2007-12-19 |
0 |
2007-12-19 |
2,732,613 |
Premium* |
|
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-01-29 |
0 |
2008-05-15 |
6,296,046 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-06-10 |
4 |
B |
$3.23 |
$164,730 |
I/I |
51,000 |
3,072,560 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-06-09 |
4 |
B |
$3.36 |
$112,896 |
I/I |
33,600 |
3,070,520 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-06-06 |
4 |
B |
$3.43 |
$343,000 |
I/I |
100,000 |
3,069,180 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-06-05 |
4 |
B |
$3.15 |
$967,000 |
I/I |
300,000 |
3,065,180 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-06-04 |
4 |
B |
$2.99 |
$74,750 |
I/I |
25,000 |
3,053,180 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-06-03 |
4 |
B |
$3.03 |
$1,214,212 |
I/I |
400,730 |
3,052,180 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-05-15 |
4 |
B |
$5.00 |
$12,500 |
I/I |
2,500 |
6,296,046 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-05-07 |
4 |
B |
$5.00 |
$12,500 |
I/I |
2,500 |
6,293,546 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-05-02 |
4 |
B |
$3.88 |
$194,000 |
I/I |
50,000 |
3,036,140 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-05-01 |
4 |
B |
$3.75 |
$393,750 |
I/I |
105,000 |
3,034,140 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-04-01 |
4 |
B |
$3.16 |
$951,913 |
I/I |
301,000 |
3,005,650 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-28 |
4 |
B |
$2.90 |
$72,460 |
I/I |
25,000 |
2,985,600 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-03-20 |
4 |
B |
$5.00 |
$6,731,000 |
I/I |
1,340,300 |
270,862 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-03-18 |
4 |
B |
$7.50 |
$6,000 |
I/I |
800 |
5,040,746 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-18 |
4 |
B |
$3.12 |
$508,593 |
I/I |
163,000 |
2,984,350 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-14 |
4 |
B |
$3.32 |
$1,540,366 |
I/I |
463,000 |
2,977,700 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-13 |
4 |
B |
$3.37 |
$50,054 |
I/I |
14,820 |
2,949,920 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-13 |
4 |
B |
$3.37 |
$784,180 |
I/I |
232,180 |
55,205,500 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-12 |
4 |
B |
$3.35 |
$88,587 |
I/I |
26,400 |
2,935,100 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-03-12 |
4 |
B |
$5.00 |
$37,000 |
I/I |
7,400 |
5,039,946 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-12 |
4 |
B |
$3.35 |
$1,387,857 |
I/I |
413,600 |
54,973,320 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-03-11 |
4 |
B |
$3.08 |
$6,137,500 |
I/I |
1,937,900 |
5,032,546 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-11 |
4 |
B |
$3.30 |
$2,049,121 |
I/I |
619,000 |
2,908,700 |
1.5 |
- |
|
| XTLBY |
XTL Biopharmaceuticals Lt... |
10% Owner |
– – • |
2008-03-10 |
4 |
B |
$3.15 |
$4,573,930 |
I/I |
1,420,000 |
2,866,800 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-03-10 |
4 |
B |
$5.00 |
$2,540,250 |
I/I |
342,200 |
180,862 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
